Viridian Therapeutics (VRDN)
(Delayed Data from NSDQ)
$11.95 USD
+0.01 (0.08%)
Updated May 31, 2024 04:00 PM ET
After-Market: $11.94 -0.01 (-0.08%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Viridian Therapeutics, Inc. [VRDN]
Reports for Purchase
Showing records 41 - 60 ( 85 total )
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Change At The Top As VRDN Appoints New President, CEO
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology - Feeling Busier than Usual? Revisiting Biotech Catalyst Activity
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Viridian?s VRDN-001 Is a Hit at All Doses Tested; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
When Less Is More (or the Same): 3mg/kg VRDN-001 Data Looks Consistent
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Party Crasher: Viridian Offers Disruption in Blockbuster TED Market; Initiate With Buy and $35 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Execution Remains On Display While VRDN-001 Data Looks Compelling
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
ATA Update Offers Closer Look At VRDN-001 - Additional Data Still To Come
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
With VRDN-001 Data In Hand, Layering In The Financing
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Eye-Popping Data Arrives For VRDN IGF1R Franchise - Seeing Clearly Now
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Notes From The (Virtual) Road... Ahead of the One/Two Punch (''001/''002 Data
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Notes From the (Virtual) Road... Ahead of the One/Two Punch (''001/''002 Data)
Provider: Wedbush Securities Inc.
Analyst: CHICO L